levonorgestrel has been researched along with Atrophy in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Graham, CT; Manek, S; McCluggage, WG; Phillips, V | 1 |
| Chittacharoen, A; Manonai, J; Theppisai, U | 1 |
| Affandi, B; Butt, AR; Findlay, JK; Marsh, MM; Riley, SC; Rogers, PA; Salamonsen, LA; Susil, B | 1 |
| Haukkamaa, M; Holmström, T; Lähteenmäki, P; Rutanen, EM; Suhonen, S | 1 |
| Kauppila, A; Penttinen, J; Rutanen, EM; Sundström, H; Suvanto-Luukkonen, E | 1 |
| Kauppila, A; Malinen, H; Penttinen, J; Sundström, H; Suvanto-Luukkonen, E | 1 |
| Varma, TR | 1 |
| Arko, H; Haukkamaa, M; Luukkainen, T; Nilsson, CG; Silverberg, SG | 1 |
2 trial(s) available for levonorgestrel and Atrophy
| Article | Year |
|---|---|
Effect of estradiol valerate and levonorgestrel on vaginal health.
Topics: Atrophy; Estradiol; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Middle Aged; Postmenopause; Prospective Studies; Treatment Outcome; Vagina; Vaginal Diseases | 2004 |
Endometrial response to hormone replacement therapy as assessed by expression of insulin-like growth factor-binding protein-1 in the endometrium.
Topics: Atrophy; Drug Implants; Endometrium; Estrogen Replacement Therapy; Female; Humans; Immunohistochemistry; Insulin-Like Growth Factor Binding Protein 1; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Progesterone Congeners | 1996 |
6 other study(ies) available for levonorgestrel and Atrophy
| Article | Year |
|---|---|
The effects of the levonorgestrel intrauterine system (Mirena coil) on endometrial morphology.
Topics: Adult; Atrophy; Contraceptive Agents, Female; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Leukemic Infiltration; Levonorgestrel; Middle Aged; Progesterone Congeners | 2003 |
Immunolocalization of endothelin and neutral endopeptidase in the endometrium of users of subdermally implanted levonorgestrel (Norplant).
Topics: Atrophy; Biopsy; Contraceptives, Oral, Synthetic; Drug Implants; Endometrium; Endothelins; Estradiol; Female; Humans; Immunohistochemistry; Indonesia; Levonorgestrel; Progesterone; Time Factors; Uterine Hemorrhage | 1995 |
Insulin-like growth factor-binding protein-1: a biochemical marker of endometrial response to progestin during hormone replacement therapy.
Topics: Administration, Cutaneous; Administration, Intravaginal; Administration, Oral; Atrophy; Climacteric; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Insulin-Like Growth Factor Binding Protein 1; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Progesterone; Treatment Outcome | 1995 |
Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
Topics: Administration, Oral; Atrophy; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Gels; Humans; Intrauterine Devices; Levonorgestrel; Menopause; Middle Aged; Prospective Studies; Time Factors | 1998 |
Effect of long-term therapy with estrogen and progesterone on the endometrium of post-menopausal women.
Topics: Aged; Atrophy; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dydrogesterone; Endometrium; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Hyperplasia; Levonorgestrel; Menopause; Middle Aged; Norethindrone; Norgestrel; Progestins; Time Factors | 1985 |
Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices.
Topics: Adolescent; Adult; Atrophy; Endometrium; Female; Humans; Inflammation; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Necrosis; Norgestrel; Time Factors | 1986 |